A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
October 30, 2018
End Date
September 22, 2020
Administered By
Pediatrics, Neurology
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
October 30, 2018
End Date
September 22, 2020